EMILY GAUER: Open Payments
NPI 1891219820 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,394 in 37 payments from 13 companies in 2025. Trend: 2023 $190 · 2024 $375 · 2025 $3,394
Speaker / faculty: $2,300Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 4 | $2,348 |
| Tandem Diabetes Care, Inc. | 2 | $234 |
| Sequel Med Tech, LLC | 3 | $229 |
| Novo Nordisk Inc | 14 | $152 |
| BETA BIONICS, INC. | 2 | $148 |
| Medtronic, Inc. | 2 | $100 |
| Mannkind Corporation | 2 | $44 |
| ABBVIE INC. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
Products named: Omnipod, t:slim X2 Insulin Pump with Control-IQ, TWIIST, iLet Bionic Pancreas, MINIMED 780G, Rybelsus, Ozempic, AFREZZA.
Industry payments across IN — which companies pay providers there.
